645 related articles for article (PubMed ID: 32106787)
1. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
[TBL] [Abstract][Full Text] [Related]
3. Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus.
Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
PLoS One; 2015; 10(3):e0119911. PubMed ID: 25781014
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
[TBL] [Abstract][Full Text] [Related]
5. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
[TBL] [Abstract][Full Text] [Related]
7. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of psychiatric syndrome in patients with systemic lupus erythematosus.
Geng W; Zhang S; Cao J; Hong X; Duan Y; Jiang Y; Wei J
Front Immunol; 2024; 15():1323209. PubMed ID: 38585267
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.
Hanly JG; Urowitz MB; Su L; Bae SC; Gordon C; Clarke A; Bernatsky S; Vasudevan A; Isenberg D; Rahman A; Wallace DJ; Fortin PR; Gladman D; Romero-Diaz J; Sanchez-Guerrero J; Dooley MA; Bruce I; Steinsson K; Khamashta M; Manzi S; Ramsey-Goldman R; Sturfelt G; Nived O; van Vollenhoven R; Ramos-Casals M; Aranow C; Mackay M; Kalunian K; Alarcón GS; Fessler BJ; Ruiz-Irastorza G; Petri M; Lim S; Kamen D; Peschken C; Farewell V; Thompson K; Theriault C; Merrill JT
Ann Rheum Dis; 2011 Oct; 70(10):1726-32. PubMed ID: 21893582
[TBL] [Abstract][Full Text] [Related]
10. Association of antiphosphatidylserine/prothrombin antibodies with neuropsychiatric systemic lupus erythematosus.
Syuto T; Shimizu A; Takeuchi Y; Tanaka S; Hasegawa M; Nagai Y; Tamura A; Ishikawa O
Clin Rheumatol; 2009 Jul; 28(7):841-5. PubMed ID: 19224124
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort.
Borowoy AM; Pope JE; Silverman E; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman D; Urowitz M; Zummer M; Hudson M; Tucker L; Peschken C
Semin Arthritis Rheum; 2012 Oct; 42(2):179-85. PubMed ID: 22595642
[TBL] [Abstract][Full Text] [Related]
12. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
14. Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus.
Jia J; Xie J; Li H; Wei H; Li X; Hu J; Meng D; Zhang Y; Zhang X
Lupus; 2019 Aug; 28(9):1128-1133. PubMed ID: 31315530
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.
Sciascia S; Bertolaccini ML; Roccatello D; Khamashta MA; Sanna G
J Neurol; 2014 Sep; 261(9):1706-14. PubMed ID: 24952022
[TBL] [Abstract][Full Text] [Related]
16. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.
Schneebaum AB; Singleton JD; West SG; Blodgett JK; Allen LG; Cheronis JC; Kotzin BL
Am J Med; 1991 Jan; 90(1):54-62. PubMed ID: 1986591
[TBL] [Abstract][Full Text] [Related]
17. Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus.
Abdel-Nasser AM; Ghaleb RM; Mahmoud JA; Khairy W; Mahmoud RM
Clin Rheumatol; 2008 Nov; 27(11):1377-85. PubMed ID: 18481154
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?
Mader S; Jeganathan V; Arinuma Y; Fujieda Y; Dujmovic I; Drulovic J; Shimizu Y; Sakuma Y; Stern JNH; Aranow C; Mackay M; Yasuda S; Atsumi T; Hirohata S; Diamond B
Arthritis Rheumatol; 2018 Feb; 70(2):277-286. PubMed ID: 29073350
[TBL] [Abstract][Full Text] [Related]
19. Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
Hanly JG; Li Q; Su L; Urowitz MB; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Steinsson K; Ramsey-Goldman R; Zoma AA; Manzi S; Nived O; Jonsen A; Khamashta MA; Alarcón GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Ramos-Casals M; Lim SS; Inanc M; Kalunian KC; Jacobsen S; Peschken CA; Kamen DL; Askanase A; Theriault C; Farewell V
Arthritis Rheumatol; 2019 Feb; 71(2):281-289. PubMed ID: 30375754
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus.
Szmyrka M; Pokryszko-Dragan A; Słotwiński K; Gruszka E; Korman L; Podemski R; Wiland P
Adv Clin Exp Med; 2019 Feb; 28(2):185-192. PubMed ID: 29963787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
